TrialJournal of medical virology2021

Efficacy and safety of sofosbuvir plus daclatasvir or ravidasvir in patients with COVID-19: A randomized controlled trial.

Sherif Abbass et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.